Childhood cancer survivorship and late effects: The landscape in India in 2020.

Autor: Arora RS; Pediatric Oncology Disease Management Group, Max Super Speciality Hospital Saket, New Delhi, 110017, India.; Cankids, New Delhi, India., Arora PR; Milann Fertility Centre, New Delhi, India., Seth R; All India Institute of Medical Sciences, New Delhi, India., Sharma S; Cankids, New Delhi, India., Kumar C; Cankids, New Delhi, India., Dhamankar V; Indian Cancer Society, Mumbai, India., Kurkure P; Indian Cancer Society, Mumbai, India.; Narayana Health SRCC Children's Hospital, Mumbai, India., Prasad M; Tata Memorial Hospital, Mumbai, India.

Publikováno v: Pediatric blood & cancer [Pediatr Blood Cancer] 2020 Sep; Vol. 67 (9), pp. e28556. Date of Electronic Publication: 2020 Jul 10.

Key Factors for Improving Predictive Accuracy and Avoiding Overparameterization of the PBPK Absorption Model in Food Effect Studies of Weakly Basic Water-Insoluble Compounds in Immediate Release Formulations.

Autor: Zhang, Miao^1,2 (AUTHOR) mia.zhang@northeastern.edu, Zhang, Shudong³ (AUTHOR), Wang, Lin³ (AUTHOR), Zhang, Zhe³ (AUTHOR), Hu, Qin³ (AUTHOR) huqin@bidc.org.cn, Liu, Dongyang¹ (AUTHOR) huqin@bidc.org.cn

Publikováno v: Pharmaceutics. Oct2024, Vol. 16 Issue 10, p1324. 20p.

Use of Physiologically Based Pharmacokinetic (PBPK) Modeling for Predicting Drug-Food Interactions: an Industry Perspective.

Autor: Riedmaier AE; DMPK and Translational Modeling, AbbVie Inc., North Chicago, Illinois, USA. arian.emamiriedmaier@abbvie.com., DeMent K; Global DMPK, Takeda Pharmaceutical Co., Ltd., San Diego, California, USA., Huckle J; Drug Product Technology, Amgen, Thousand Oaks, California, USA., Bransford P; Modeling & Informatics, Vertex Pharmaceuticals, Boston, Massachusetts, USA., Stillhart C; Pharmaceutical R&D, Formulation & Process Sciences, F. Hoffmann-La Roche Ltd., Basel, Switzerland., Lloyd R; Computational & Modelling Sciences, Platform Technology Sciences, GlaxoSmithKline R&D, Ware, Hertfordshire, UK., Alluri R; Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Cambridge, UK., Basu S; Pharmacokinetic, Pharmacodynamic and Drug Metabolism-Quantitative Pharmacology and Pharmacometrics (PPDM-QP2), Merck & Co, Inc., West Point, Pennsylvania, USA., Chen Y; Department of Drug Metabolism and Pharmacokinetics, Genentech, South San Francisco, California, USA., Dhamankar V; Formulation Development, Vertex Pharmaceuticals, Boston, Massachusetts, USA.; Formulation Development, Cyclerion Therapeutics Inc., Cambridge, Massachusetts, USA., Dodd S; Chemical & Pharmaceutical Profiling, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, USA., Kulkarni P; Department of Pharmacokinetics and Drug Metabolism, Amgen Inc., Cambridge, Massachusetts, USA., Olivares-Morales A; Pharmaceutical Sciences, Roche Pharmaceutical Research and Early Development, Roche Innovation Center, Basel, Switzerland., Peng CC; Department of Pharmacokinetics and Drug Metabolism, Amgen Inc., Cambridge, Massachusetts, USA.; Drug Metabolism and Pharmacokinetics, Theravance Biopharma, South San Francisco, California, USA., Pepin X; New Modalities and Parenteral Development, Pharmaceutical Technology & Development, Operations, AstraZeneca, Macclesfield, UK., Ren X; Modeling & Simulation, PK Sciences, Novartis Institutes of Biomedical Research, East Hanover, New Jersey, USA., Tran T; Computational & Modelling Sciences, Platform Technology Sciences, GlaxoSmithKline R&D, Collegeville, Pennsylvania, USA., Tistaert C; Pharmaceutical Sciences, Janssen Research & Development, Beerse, Belgium., Heimbach T; PBPK & Biopharmaceutics, Novartis Institutes of Biomedical Research, Wayne, New Jersey, USA., Kesisoglou F; Pharmaceutical Sciences, Merck & Co., Inc., Kenilworth, New Jersey, USA., Wagner C; Pharmaceutical Technologies, Chemical and Pharmaceutical Development, Merck Healthcare KGaA, Darmstadt, Germany., Parrott N; Pharmaceutical Sciences, Roche Pharmaceutical Research and Early Development, Roche Innovation Center, Basel, Switzerland.

Publikováno v: The AAPS journal [AAPS J] 2020 Sep 27; Vol. 22 (6), pp. 123. Date of Electronic Publication: 2020 Sep 27.

Modulating nasal mucosal permeation using metabolic saturation and enzyme inhibition techniques.

Autor: Dhamankar V; Division of Pharmaceutics and Translational Therapeutics, College of Pharmacy, University of Iowa, Iowa City, IA, USA., Donovan MD; Division of Pharmaceutics and Translational Therapeutics, College of Pharmacy, University of Iowa, Iowa City, IA, USA.

Publikováno v: The Journal of pharmacy and pharmacology [J Pharm Pharmacol] 2017 Sep; Vol. 69 (9), pp. 1075-1083. Date of Electronic Publication: 2017 May 23.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.